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ABSTRACT 
A larger number of medicinal plants and their purified constituents have been shown beneficial therapeutic potentials. We present here the 
protective effects of an Indian medicinal plant Iris Kashmiriana as compared to Ofloxacin in E. coli induced peritonitis. Iris Kashmiriana is one 
of an important member of family Iridaceae, locally known as Mazarmund in Kashmir. The plant has been widely used in traditional 
medicine and modern clinical preparations to treat cold, flu, malaria, toothache, cancer, bacterial, viral infections and bruise. Rats were pre-
treated with 200 mg/kg and 400 mg/kg/bwt dose for 3 days and fourth day with E. coli (1×108 CFU/ml) strain and consecutively 3 days 
treatment. Mortality was monitored for 14 days. After the death of rats or completion of the experiment rats were sacrifice and kidney were 
used for our protocol. Colonies were count and statically analysis was done. Results showed dose dependent anti-microbial activity. 
Pretreatment of mice with Iris Kashmiriana improved bacterial clearance as well as improved phagocytic and intracellular bactericidal 
capacities of neutrophils. In the Ofloxacin treated mice although bacterial clearance was rapid, polymorph phagocytosis was depressed. Thus 
the results, obtained justify the traditional use of Iris Kashmiriana. 
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INTRODUCTION 
Interest in medicinal plants has burgeoned due to 
increased efficiency of new plant-derived drugs and the 
growing interest in natural products. Because of the 
concerns about the side effects of conventional medicine, 
the use of natural products as an alternative to 
conventional treatment in healing and treatment of various 
diseases has been on the rise in the last few decades. The 
use of plants as medicines dates from the earliest years of 
man’s growth 1, 2. Medicinal plants serve as therapeutic 
alternatives, safer choices, or in some cases, as the only 
effective treatment. People in separate cultures and places 
are known to have used the same plants for similar 
medical problems. A larger number of these plants and 
their isolated constituents have shown beneficial 
therapeutic effects, including anti-oxidant, anti-
inflammatory, anti-cancer, anti-microbial and 
immunomodulatory effects1, 3-9. Intra-abdominal sepsis 
continues to be a major cause of morbidity and mortality 
following trauma and abdominal surgery for bowel 
perforations10. Treatment of this condition has till now 
been focused on appropriate surgery, supplemented with 
antimicrobial agents and good nutritional support11. An 
important factor, which influences recovery from any 
infective process, is the status of the host's defense 
mechanism10. The approach of fortifying the cellular 
immune functions to increase resistance against infections 
has only recently been recognized12. Several substances, 
such as glucans, C. parvum, BCG and levamisol have been 
reported to increase resistance to infection by augmenting 
the immune response13. Iris Kashmiriana is one of an 
important member of the family Iridaceae, locally known 
as Mazarmund in Kashmir. The plant has been widely used 
in traditional medicine and modern clinical preparations to 
treat cold, flu, malaria, toothache, cancer, bacterial, viral 
infections and bruise. The phytochemical analyses of the 
different extracts of Iris Kashmiriana have revealed the 
presence of different compounds including flavonoids, 
isoflavonoids, glycosides and tannins. The medicinal 
importance of the plant prompted isolation of a variety of 
pharmacologically active compounds including quinones, 
triterpenoids, flavonoids, isoflavonoids and stilbene 
glycosides14. In view of the immunomodulation activities of 
Iris Kashmiriana, we undertook studies to initially evaluate 
the effect of Iris Kashmiriana upon survival of mice with E. 
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coli peritonitis in comparison with a standard 
antimicrobial agent, Ofloxacin. Further studies to 
investigate the mechanism of protective effects against E. 
coli sepsis were undertaken. These induced bacterial 
clearance studies and evaluation of polymorphonuclear 
functions. 
MATERIALS AND METHODS 
Plant material 
The rhizome of Iris Kashmiriana was collected from 
district Bandipora of Jammu and Kashmir region. 
Herbarium of plant was prepared and submitted to Dr. 
Akhtar H. Malik, Curator, Centre of Biodiversity & 
Taxonomy, Department of Botany, University of Kashmir 
for authentication. Plant authentication voucher numbers 
obtained was 2625 for Iris Kashmiriana. Rhizome selected 
for the study was washed thoroughly under running tap 
water and then was rinsed in distilled water; they were 
allowed to dry for some time at room temperature. Then 
the rhizome was shade dried without any contamination 
for about 3 to 4 weeks. Dried rhizome was grinded using 
electronic grinder. Powdered plant material was observed 
for their colour, odour and texture. Dried material was 
packed in air tight container and stored for phytochemical 
and biological studies. 
Chemical reagents 
All the chemicals used in this study were obtained from 
HiMedia Laboratories Pvt. Ltd. (Mumbai, India), Sigma-
Aldrich Chemical Co. (Milwaukee, WI, USA), SD Fine-Chem 
Chem. Ltd. (Mumbai, India) and SRL Pvt. Ltd. (Mumbai, 
India).All the chemicals and solvent used in this study were 
of analytical grade. The test organisms Escherichia coli 
(MTCC 2075) were obtained from the stocks of the 
Pinnacle Biomedical Research Institute, Bharat scout guide 
bhawan, shyamla hills, Bhopal, (M.P.).  
Extraction 
Extraction was performed using continuous hot 
percolation soxhlation. Dried pulverized parts of Iris 
Kashmiriana were placed in thimble of soxhlet apparatus. 
Soxhlation was performed at 60°C using chloroform as non 
polar solvent at first. Exhausted plant material (mark) was 
dried and afterward extracted with ethyl acetate and 
methanol. Each solvent soxhlation was continued till no 
colour was observed in siphon tube. For confirmation of 
exhausted plant marc (i.e. completion of extraction) 
colourless solvent was collected from siphon tube and 
evaporated for residue. Absence of residual confirmed the 
completion of extraction. Obtained extracts were 
evaporated and using rotary vacuum evaporator (Buchi 
type) at 40°C. Dried extract was weighed and finally the 
percentage yields were calculated of the dried extracts.  
In vivo study 
Animals 
All ethical and handling guidelines were followed as set by 
Indian Legislation and approved by Institutional Animal 
Ethics Committee. All animals were procured and housed 
in animal house maintained under standard hygienic 
conditions. All animals were given standard diet (Golden 
Feed, New Delhi) and water regularly. Animal experiments 
were approved by Institutional Animal Ethics Committee 
(IAEC) of Pinnacle Biomedical Research Institute (PBRI) 
Bhopal. 
(Reg No. 1824/PO/ERe/S/15/CPCSEA). Protocol approval 
reference no. PBRI/IAEC/PN-17046. 
Acute oral toxicity 
The acute toxic class method set out in guideline is a 
stepwise procedure with the use of 3 animals of a single 
sex per step. Depending on the mortality and/or the 
moribund status of the animals, on average 2-4 steps may 
be necessary to allow judgment on the acute toxicity of the 
test substance. The substance is administered orally to a 
group of experimental animals at one of the defined doses. 
The substance is tested using a stepwise procedure, each 
step using three animals of a single sex. Absence or 
presence of compound-related mortality of the animals 
dosed at one step will determine the next step, i.e.;  no 
further testing is needed, dosing of three additional 
animals, with the same dose and dosing of three additional 
animals at the next higher or the next lower dose level. 
Three animals are used for each step. The dose level to be 
used as the starting dose is selected from one of four fixed 
levels, 5, 50, 300 and 2000 mg/kg body weight15. 
Treatment 
Animals were housed in a group of six in separate cages 
under controlled conditions of temperature (22 ± 2°C). All 
animals were given standard diet (Golden feed, New Delhi) 
and water, ad libitum. The environment was also regulated 
at 25 ± 1 0C with 12/12 h (light/dark) cycle.  Animals were 
further divided in five groups with six animals in each 
group.  
Group I: Normal control: Normal saline were 
administrated by oral route at a dose of 5ml/kg body 
weight.  
Group II: Vehicle treated with Escherichia coli treated 
group: Escherichia coli (1×108 CFU/ml) were dissolved in 
normal saline and were administrated by oral route at a 
dose of 10ml/kg body weight.  
Group III: Standard drug treated group: Ofloxacin was 
dissolved in normal saline and was administrated by oral 
route at a dose of 5m g/kg body weight 
Group IV: 200 mg/kg methanolic extract treated group: 
Extract was dissolved in normal saline and was 
administrated by oral route at a dose of 200m g/kg body 
weight. 
Group V: 400 mg/kg methanolic extract treated group: 
Extract were dissolved in normal saline and was 
administrated by oral route at a dose of 400mg/kg body 
weight.  
Preparation for bacterial inoculums 
In brief, E. coli strain (MTCC 2075) were grown on nutrient 
broth medium (3 g of beef extract, 5 g of peptone and 5 g of 
NaCl, pH 7, sterilized by autoclaving at 120°C for 30 min.) 
from a single colony and incubated at 37°C for 16-18 h to 
obtain stationary growth phase cultures. The bacteria were 
then centrifuged (200 rpm) for 10 min at 4°C and the 
pellets were resuspended in PBS to an OD of 0.1 at 660 nm, 
with a spectrophotometer, corresponding to 108 CFU/ml16. 
Systemic infection by E. coli 
To produce infection, the rats were induced by the intra-
peritoneal with suitable inoculums in a volume of 0.2 to 
0.25 ml. After infection, the rats were observed twice daily 
and animals exhibiting profound inanition or an inability to 
reach food and water were sacrificed. The experimental 
design involved administration of each of the three test 
agents by daily oral dosing for a period of 14 days. dosing 
regimens were started on days -7,-6, -5, -4, -3, -2, -1, 0, 1, 2, 
3, 4, 5, 6, 7 and relative to the day of challenge (day 0) with 
1×108 CFU of E. coli/ml. Before and after the challenged 
day animals were treated with 200 mg/kg body weight and 
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400 mg/kg body weight Iris Kashmiriana extract and 5 
mg/kg body weight Ofloxacin respectively. Survival was 
monitored for all experimental groups till 14 day. These 
conditions were in accordance with those of previously 
described method 17, with slight modification. The 
pathological status of the rat was determined by visual 
examination of internal organs after their death or sacrifice 
at the completion of the experiment. All surviving rats 
were killed by cervical dislocation on 15 day determination 
of the numbers of CFU of E. coli per gram from the kidney18, 
19. This determination was made by aseptically removing 
and weighing both kidneys, homogenizing kidneys in w/v 
ml of saline with a high speed Homogenizer (Remi RQ-
124A) and Kidney burden was determined by culturing of 
homogenates in physiological saline followed by plating 
0.1 ml aliquots onto Nutrient agar plates. The plates were 
incubated at 37°C and the number of colonies was 
enumerated after 48 h of growth20. All animal care 
procedures were supervised and approved by the 
Institutional Animals Ethics Committee (IAEC) of PBRI, 
Bhopal. 
Bacterial clearance 
E. coli was determined in the different groups by sampling 
retro blood at various intervals after 16 hrs and up to 14 
days (at which time maximum mortality will be recorded). 
The sample was serially diluted and plated on nutrient 
agar media. Incubate it at 24 hours at 37°C temperature. 
After incubation colony count was determine by colony 
counter method.  
Neutrophiles function test 
The rats were pre-treated orally with vehicle or extracts 
for 14 days. At the end of treatment day 14, blood samples 
were collected from the retro-orbital plexus into 
heparinized vials and analyzed for differential leukocyte 
count (DLC). After the initial counts, blood samples were 
incubated with 80 mg nylon fibres/ml for 15 min at 37oC. 
The incubated blood samples were again analyzed for TLC 
and DLC, respectively to give neutrophil index of blood 
samples. The percent neutrophil adhesion was calculated 
as follows: 
Neutrophil adhesion %= NIu-NIt×100/NIu 
Where,  NIu is the neutrophil index of untreated blood 
samples and  
NIt is the neutrophil index of treated blood samples. 
Sample harvesting 
After the monitoring of mortality rats were sacrificed after 
infection, at this time rats were anesthetized by inhalation 
of diethyl ether and peritoneal cavity was washed with 5 
ml of sterile PBS saline by using an 18-gauge needle and 
peritoneal lavage fluid was collected in sterile tubes for 
determination of CFU21.  
Determination of CFU 
Fifty microliters of peritoneal lavage fluid from each Rat 
were placed on ice and serially diluted with sterile saline. 
Twelve microliters of each dilution were spread on sterile 
nutrient agar plates and incubated overnight at 37°C after 
which the number of colonies was counted  
RESULTS AND DISCUSSIONS 
In previous paper phytochemical analysis, quantitative 
phytochemical assay was performed by calculating total 
phenolic content (TPC) and total flavonoids content (TFC)  
result showed that methanolic extract of Iris Kashmiriana 
has highest methanolic extractive percentage compare to 
other extracts. In the acute toxicity study, no signs of 
toxicity were found up to the dose of 2000 mg/kg body 
weight. Hence 1/10th and 1/5th doses i.e. 200 mg/kg and 
400 mg/kg have been fixed as ED50 for present study 
Table 1. 
Table 1: Acute oral toxicity of methanolic extract 
S. No. Groups 
Observations/ 
Mortality 
1. 5 mg/kg Bodyweight 0/3 
2. 50 mg/kg Bodyweight 0/3 
3. 300 mg/kg Bodyweight 0/3 
4. 2000 mg/kg Bodyweight 0/3 
 
In-vivo antimicrobial activity was tested by inducing 
peritonitis through E. coli. The activity of the extract was 
calculated by measuring the CFU/ml of the 
microorganisms. The experiment was done in groups of 5 
containing control, vehicle, standard (5mg/kg), extract 
(200 mg/kg) and extract (400 mg/kg). The results 
obtained indicated a dose dependent antimicrobial activity 
of the extracts; the extract given at a concentration of 400 
mg/kg had better activity than the one administered at 200 
mg/kg Table 2& Fig. 1. 
Table 2: In-Vivo antimicrobial activity in E. coli induced 
peritonitis 
S. No. Groups CFU/ml 
1. Normal Control 105.50±5.089 
2. Vehicle control 277.67±6.532 
3. Standard (5 mg/kg BW) 80.00±6.753 
4. Extract (200 mg/kg BW) 201.50±7.369 
5. Extract (400 mg/kg BW) 128.33±13.155 
 
 
Figure 1: E. coli induced peritonitis 
Neutrophil adhesion test is an indication of the 
marginalization of phagocytic cells in the blood vessels, i.e. 
an indication of immunostimulation. Increase in % 
neutrophil adhesion is attributed to marginalization of 
phagocytic cells which reflects improvement in defensive 
response under normal circumstances Table 3. 
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Table 3: Neutrophiles function test 
S. No. Groups 
Neutrophiles % 
Neutrophiles Adhesion 
Untreated Treated 
1. Normal Control 25.60±1.416 23.91±0.774 17.84±5.752 
2. Vehicle Control 24.34±0.934 23.91±0.866 6.01±0.974 
3. Standard (5 mg/kg BW) 27.04±3.996 24.38±0.861 30.25±8.113 
4. Extract (200 mg/kg BW) 24.53±0.903 23.81±0.824 27.97±4.597 
5. Extract (400 mg/kg BW) 26.60±1.157 21.25±1.061 29.65±2.014 
 
CONCLUSION 
The present study demonstrates clearly that pretreatment 
with Iris Kashmiriana protect mice against mortality due to 
induced E. coli sepsis and this is comparable to Ofloxacin. 
This is associated with a rapid clearance of bacteremia, 
mediated probably through a stimulation of phagocytic and 
bacterial function of polymorphs. It appears therefore that 
activation of neutrophils by Iris Kashmiriana leads to a 
rapid bacterial clearance thus affording protection against 
E. coli induced peritonitis and morality. Extrapolation of 
animal data to a clinical setting is not always appropriate. 
However, the results obtained with Iris Kashmiriana in this 
study coupled with its relative lack of toxicity and oral 
efficacy suggests that it may prove to be useful therapeutic 
modality in patients with abdominal sepsis. The observed 
potential can be attributed to the presence of phenolic 
compounds and flavonoids present in plant. Further 
detailed study is required to pinpoint the exact mechanism 
and active principle involved in it. 
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